Short interference RNAs in glomerulonephritis: A mini review
Open Access
- 30 June 2026
- journal article
- Published by Maad Rayan Publishing Company in BioImpacts
- Vol. 16 (1) , 32812
Abstract
Glomerulonephritis (GN) is a heterogeneous group of kidney diseases characterized by inflammation and damage to the glomeruli. Current treatments for GN remain suboptimal, creating a pressing need for innovative therapeutic strategies. Short interfering RNAs (siRNAs) represent a promising advance in the therapeutic landscape for GN, offering targeted gene silencing that could fundamentally transform the management of this significant cause of kidney disease. siRNA therapies work by selectively silencing specific genes involved in the pathogenesis of GNs, including interferon pathways, B cell activation, TGF-β, MAPK1, HMGB1, BLYSS, and SIRT1. Preclinical evidence demonstrates improved kidney function and reduced glomerular damage in experimental models. While challenges remain in translating these findings to clinical applications, ongoing research suggests that siRNA-based therapies have the potential to transform the treatment of GN, offering new hope for patients with this challenging kidney disease. This review highlights the impact of siRNA-based therapies in GN, exploring their mechanisms, delivery systems, challenges, and preclinical and clinical evidence.Keywords
This publication has 67 references indexed in Scilit:
- Canonical effects of cytokines on glomerulonephritis: A new outlook in nephrologyMedicinal Research Reviews, 2024
- Lumasiran: A Review in Primary Hyperoxaluria Type 1Drugs, 2024
- siRNA‐based nanotherapeutics as emerging modalities for immune‐mediated diseases: A preliminary reviewCell Biology International, 2022
- The potential of RNA-based therapy for kidney diseasesPediatric Nephrology, 2022
- Knocking Down Barriers: Advances in siRNA DeliveryChemistrySelect, 2021
- RNA Interference: Story and Mechanisms2021
- Glucocorticoid receptors and their upstream epigenetic regulators in adults with steroid-resistant nephrotic syndromeBioFactors, 2020
- Dicer and Drosha expression in patients with nephrotic syndromeBioFactors, 2020
- Clinical features and long-term renal outcomes of Japanese patients with obesity-related glomerulopathyClinical and Experimental Nephrology, 2012
- In Vivo Transfer of Small Interfering RNA or Small Hairpin RNA Targeting Glomeruli2008